The multiscale backbone of the human phenotype network based on biological pathways

BioData Mining

Volumn 7, Issue 1, 2014, Pages

  Darabos, Christian ^a   White, Marquitta J ^a,b   Graham, Britney E ^a   Leung, Derek N ^a   Williams, Scott M ^a   Moore, Jason H ^a  

^a DARTMOUTH COLLEGE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biological pathways; Diseasome; GWAS; Information theory; Network; Phenotypes

Indexed keywords

EID: 84892714921     PISSN: None     EISSN: 17560381     Source Type: Journal    
DOI: 10.1186/1756-0381-7-1     Document Type: Article

References (45)

1. The human disease network. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL, Proc Nat Acad Sci 2007 104 21 8685 8690 10.1073/pnas.0701361104 17502601 (Pubitemid 47175372)
2. Systems biology and the future of medicine. Loscalzo J, Barabasi AL, Wiley Interdisciplinary Rev: Syst Biol Med 2011 3 6 619 627 10.1002/wsbm.144
3. Network-based global inference of human disease genes. Wu X, Jiang R, Zhang MQ, Li S, Mol Syst Biol 2008 4 189 18463613
4. Network properties of complex human disease genes identified through genome-wide association studies. Barrenas F, Chavali S, Holme P, Mobini R, Benson M, PLoS ONE 2009 4 11 8090 10.1371/journal.pone.0008090
5. Inferring human phenotype networks from genome-wide genetic associations. Darabos C, Desai K, Cowper-Sal-lari R, Giacobini M, Lupien M, Moore JH, Evolutionary Computation, Machine Learning and Data Mining in Bioinformatics-11th European Conference, EvoBIO 2013, Proceedings Lecture Notes in Computer Science Vienna, Austria: Springer, Giacobini M, Vanneschi L, Bush WS, 2013
6. Extracting the multiscale backbone of complex weighted networks. Serrano MÁ Boguñá M, Vespignani A, Proc Nat Acad Sci 2009 106 16 6483 6488 10.1073/pnas.0808904106 19357301
7. Metabolic pathway analysis: basic concepts and scientific applications in the post-genomic era. Schilling CH, Schuster S, Palsson BO, Heinrich R, Biotechnol Prog 1999 15 3 296 303 10.1021/bp990048k 10356246 (Pubitemid 29270673)
8. Newman M, Networks: An Introduction New York, NY, USA: Oxford University Press, Inc. 2010
9. Collective dynamics of "small-world" networks. Watts DJ, Strogatz SH, Nature 1998 393 440 442 10.1038/30918 9623998 (Pubitemid 28292183)
10. Bipartite network projection and personal recommendation. Zhou T, Ren J, Medo Mcv, Zhang YC, Phys Rev E 2007 76 046115
11. Complex-disease networks of trait-associated single-nucleotide polymorphisms (SNPs) unveiled by information theory. Li H, Lee Y, Chen JL, Rebman E, Li J, Lussier YA, J Am Med Inform Assoc: JAMIA 2012 19 2 295 305 10.1136/amiajnl-2011-000482
12. Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. Suthram S, Dudley JT, Chiang AP, Chen R, Hastie TJ, Butte AJ, PLoS Comput Biol 2010 6 2 1000662 10.1371/journal.pcbi.1000662
13. Mapping the umls semantic network into general ontologies. Burgun A, Bodenreider O, Proc AMIA Symp 2001 81 85 http://www.ncbi.nlm.nih.gov/pubmed/ 11833483/
14. Modularity and community structure in networks. Newman MEJ, Proc Nat Acad Sci 2006 103 23 8577 8582 10.1073/pnas.0601602103 16723398 (Pubitemid 43878062)
15. Fast unfolding of communities in large networks. Blondel VD, Guillaume JL, Lambiotte R, Lefebvre E, J Stat Mechanics: Theory and Experiment 2008 2008 10 10008 10.1088/1742-5468/2008/10/P10008
16. Community detection algorithms: A comparative analysis. Lancichinetti A, Fortunato S, Phys Rev E 2009 80 056117
17. Apolipoprotein e: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial alzheimer disease. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD, Proc Natl Acad Sci U S A 1993 90 5 1977 1981 10.1073/pnas.90.5. 1977 8446617 (Pubitemid 23069980)
18. Apolipoprotein e polymorphism and alzheimer's disease. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S, Lancet 1993 342 8873 697 699 10.1016/0140-6736(93)91705-Q 8103819 (Pubitemid 23279761)
19. The association of the apolipoprotein e gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations. Viiri LE, Loimaala A, Nenonen A, Islam S, Vuori I, Karhunen PJ, Lehtimaki T, Atherosclerosis 2005 179 1 161 167 10.1016/j.atherosclerosis.2004.10.004 15721023 (Pubitemid 40249799)
20. Genetic variants of apoe account for variability of plasma low-density lipoprotein and apolipoprotein b levels in fhbl. Yue P, Isley WL, Harris WS, Rosipal S, Akin CD, Schonfeld G, Atherosclerosis 2005 178 1 107 113 10.1016/j.atherosclerosis.2004.06.020 15585207 (Pubitemid 39600822)
21. Analysis of lipid pathway genes indicates association of sequence variation near srebf1/tom1l2/atpaf2 with dementia risk. Reynolds CA, Hong MG, Eriksson UK, Blennow K, Wiklund F, Johansson B, Malmberg B, Berg S, Alexeyenko A, Gronberg H, Gatz M, Pedersen NL, Prince JA, Hum Mol Genet 2010 19 10 2068 2078 10.1093/hmg/ddq079 20167577
22. Regulation of apolipoprotein e secretion by high density lipoprotein 3 in mouse macrophages. Dory L, J Lipid Res 1991 32 5 783 792 2072040
23. Classification and prediction of clinical alzheimer's diagnosis based on plasma signaling proteins. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T, Nat Med 2007 13 11 1359 1362 10.1038/nm1653 17934472 (Pubitemid 350073592)
24. Apolipoprotein e, cholesterol metabolism, diabetes, and the convergence of risk factors for alzheimer's disease and cardiovascular disease. Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, Martins RN, Mol Psychiatry 2006 11 8 721 736 10.1038/sj.mp.4001854 16786033 (Pubitemid 44141805)
25. Molecular genetics of alzheimer's disease: an update. Brouwers N, Sleegers K, Van Broeckhoven C, Ann Med 2008 40 8 562 583 10.1080/ 07853890802186905 18608129
26. The pursuit of susceptibility genes for alzheimer's disease: progress and prospects. Sleegers K, Lambert JC, Bertram L, Cruts M, Amouyel P, Van Broeckhoven C, Trends Genet 2010 26 2 84 93 10.1016/j.tig.2009.12.004 20080314
27. Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory. Lukowski AF, Koss M, Burden MJ, Jonides J, Nelson CA, Kaciroti N, Jimenez E, Lozoff B, Nutr Neurosci 2010 13 2 54 70 10.1179/147683010X12611460763689 20406573
28. Effect of iron-deficiency anemia on cognitive skills and neuromaturation in infancy and childhood. Walter T, Food Nutr Bull 2003 24 4 Suppl 104 110 12664529
29. The neurophysiological performance of visuospatial working memory in children with developmental coordination disorder. Alloway TP, Dev Med Child Neurol 2012 54 12 1075 1076 10.1111/j.1469-8749.2012.04427.x 23066641
30. The role of iron in learning and memory. Fretham SJB, Carlson ES, Georgieff MK, Adv Nutr 2011 2 2 112 121 10.3945/an.110.000190 22332040
31. Iron deficiency and brain development. Lozoff B, Georgieff MK, Semin Pediatr Neurol 2006 13 3 158 165 10.1016/j.spen.2006.08.004 17101454 (Pubitemid 44712046)
32. Body iron is associated with cognitive executive planning function in college women. Blanton CA, Green MW, Kretsch MJ, Br J Nutr 2013 109 5 906 913 10.1017/S0007114512002620 22676919
33. Von willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Castaman G, Federici AB, Rodeghiero F, Mannucci PM, Haematologica 2003 88 1 94 108 12551832 (Pubitemid 36168860)
34. Vwf and fviii: the origins of a great friendship. Haberichter SL, Blood 2009 113 13 2873 2874 10.1182/blood-2009-01-199844 19324909
35. Von willebrand factor and thrombosis. Franchini M, Lippi G, Ann Hematol 2006 85 7 415 423 10.1007/s00277-006-0085-5 16568319 (Pubitemid 44283106)
36. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (lite). Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR, Am J Med 2002 113 8 636 642 10.1016/S0002-9343(02)01345-1 12505113 (Pubitemid 36015799)
37. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. european concerted action on thrombosis and disabilities angina pectoris study group. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC, N Engl J Med 1995 332 10 635 641 10.1056/NEJM199503093321003 7845427
38. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the minnesota heart survey. McGovern PG, Jacobs DRJ, Shahar E, Arnett DK, Folsom AR, Blackburn H, Luepker RV, Circulation 2001 104 1 19 24 10.1161/01.CIR.104.1.19 11435332 (Pubitemid 32623284)
39. Sticky business: von willebrand factor in inflammation. López J, Blood 2006 108 12 3627 3627 10.1182/blood-2006-09-046474 (Pubitemid 44864530)
40. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, Niessen WJ, Breteler MMB, Brain 2010 133 Pt 4 1163 1172 20375138
41. Association between circulating hemostatic measures and dementia or cognitive impairment: systematic review and meta-analyzes. Quinn TJ, Gallacher J, Deary IJ, Lowe GDO, Fenton C, Stott DJ, J Thromb Haemost 2011 9 8 1475 1482 10.1111/j.1538-7836.2011.04403.x 21676170
42. Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volume. Kliper E, Bashat DB, Bornstein NM, Shenhar-Tsarfaty S, Hallevi H, Auriel E, Shopin L, Bloch S, Berliner S, Giladi N, Goldbourt U, Shapira I, Korczyn AD, Assayag EB, Stroke 2013 44 5 1433 1435 10.1161/STROKEAHA.111.000536 23444307
43. Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the aric study. Alonso A, Tang W, Agarwal SK, Soliman EZ, Chamberlain AM, Folsom AR, Int J Cardiol 2012 155 2 217 222 10.1016/j.ijcard. 2010.09.051 20965585
44. Atrial fibrillation is associated with impaired cognitive function and hippocampal atrophy: silent cerebral ischaemia vs. alzheimer's disease? Goette A, Braun-Dullaeus RC, Eur Heart J 2008 29 17 2067 2069 10.1093/eurheartj/ehn343 18676399
45. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Knecht S, Oelschlager C, Duning T, Lohmann H, Albers J, Stehling C, Heindel W, Breithardt G, Berger K, Ringelstein EB, Kirchhof P, Wersching H, Eur Heart J 2008 29 17 2125 2132 10.1093/eurheartj/ ehn341 18667399